Literature DB >> 21795819

Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis.

Muayad Aghali Merza1, Parissa Farnia, Payam Tabarsi, Mehdi Khazampour, Mohammad Reza Masjedi, Ali Akbar Velayati.   

Abstract

INTRODUCTION: This study aimed to determine first-line anti-tuberculosis drug resistance rates in new and previously treated cases and to identify risk factors associated with multidrug resistant tuberculosis (MDR-TB) at the National Reference Tuberculosis Laboratory of Iran.
METHODOLOGY: This was a retrospective analysis of all confirmed TB patients from December 2000 to June 2005. Drug susceptibility testing to isoniazid, rifampicin, streptomycin, ethambutol and pyrazinamide was performed on Löwenstein-Jensen (LJ) medium according to the proportion method.
RESULTS: Mycobacterium tuberculosis strains were isolated from 1,742 patients with TB, of whom 935 (53.7%) were male. The mean age of patients was 44.2 ± 17.4 years (SD). A total of 1,074 patients were native Iranians while 668 (38.3%) were immigrant patients. Out of 1,139 (65.4%) new cases, 340 (29.9%) had at least one drug resistance. Of 603 (34.6%) previously treated cases, 416 (69.0%) had resistant strains. There were 263 patients (15.1%) with MDR-TB, 72 of whom were new (6.3% of all new cases) and 191 were previously treated (31.7% of all previously treated cases). Factors associated with MDR-TB included age under 45 years, male sex, previous TB treatment, immigration, poor living conditions, and unemployment.
CONCLUSIONS: The high rate of initial resistance in MDR-TB cases and the high rate of MDR-TB in a young age group were indicators of recent transmission. Therefore, closer monitoring of transmission trends of drug resistant strains should be considered as priority, to ensure a successful TB control programme.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795819     DOI: 10.3855/jidc.1259

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  20 in total

Review 1.  Primary ethambutol resistance among Iranian pulmonary tuberculosis patients: a systematic review.

Authors:  Mohammad Javad Nasiri; Abbas Ali Imani Fooladi; Hossein Dabiri; Ali Pormohammad; Alireza Salimi Chirani; Masoud Dadashi; Hamidreza Houri; Mohsen Heidary; Mohammad Mehdi Feizabadi
Journal:  Ther Adv Infect Dis       Date:  2016-08-10

2.  Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.

Authors:  Wondemagegn Mulu; Daniel Mekonnen; Mulat Yimer; Aschalew Admassu; Bayeh Abera
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

3.  Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran.

Authors:  Aliasghar Farazi; Masoomeh Sofian; Nader Zarrinfar; Fatemeh Katebi; Seyed Davood Hoseini; Roohollah Keshavarz
Journal:  Caspian J Intern Med       Date:  2013

4.  Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia.

Authors:  Kedir Abdella; Ketema Abdissa; Wakjira Kebede; Gemeda Abebe
Journal:  BMC Public Health       Date:  2015-07-02       Impact factor: 3.295

5.  A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients.

Authors:  Mohammad Varahram; Mohammad Javad Nasiri; Parissa Farnia; Mohadese Mozafari; Ali Akbar Velayati
Journal:  Open Microbiol J       Date:  2014-02-07

6.  Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran.

Authors:  Leyla Sahebi; Khalil Ansarin; Parviz Mohajeri; Majid Khalili; Amir Monfaredan; Safar Farajnia; Simin Khayyat Zadeh
Journal:  Open Respir Med J       Date:  2016-06-30

7.  Hematological and liver toxicity of anti-tuberculosis drugs.

Authors:  Maryam-Sadat Mirlohi; Alireza Ekrami; Saeed Shirali; Mehdi Ghobeishavi; Fatemeh Pourmotahari
Journal:  Electron Physician       Date:  2016-09-20

8.  Molecular typing and drug sensitivity testing of Mycobacterium tuberculosis isolated by a community-based survey in Ethiopia.

Authors:  Muluwork Getahun; Gobena Ameni; Abebaw Kebede; Zelalem Yaregal; Elena Hailu; Grimay Medihn; Daniel Demssie; Feven Girmachew; Yetnebersh Fiseha; Abyot Meaza; Nathneal Dirse; Mulualem Agonafir; Feleke Dana; Fasil Tsegaye; Zeleke Alebachew; Almaz Abebe; Amha Kebede; Eshetu Lemma
Journal:  BMC Public Health       Date:  2015-08-06       Impact factor: 3.295

9.  Molecular Epidemiology Analysis of TB in Five Regional States of Iran.

Authors:  Parvaneh Ravan; Parisa Farnia; Nour Amirmozafari; Kimia Taghavi; Mojtaba Ahmadi; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  Tanaffos       Date:  2013

Review 10.  First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review.

Authors:  Babak Pourakbari; Setareh Mamishi; Mona Mohammadzadeh; Shima Mahmoudi
Journal:  Front Microbiol       Date:  2016-07-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.